|1.||Jiang, Yajian: 1 article (12/2015)|
|2.||Lu, Lingping: 1 article (12/2015)|
|3.||Ke, Qing: 1 article (12/2015)|
|4.||Qi, Ming: 1 article (12/2015)|
|5.||He, Fangping: 1 article (12/2015)|
|6.||Weng, Chen: 1 article (12/2015)|
|7.||Yu, Ping: 1 article (12/2015)|
|8.||Huang, Hui: 1 article (12/2015)|
|9.||Yi, Xin: 1 article (12/2015)|
|10.||Sica, Domenic A: 1 article (04/2015)|
|1.||Hypertension (High Blood Pressure)
02/01/1997 - "The triamterene therapy was effective in correcting the endocrine and metabolic disorders as well as arterial hypertension, but did not prevent a deficit in mental and physical development. "
01/01/1994 - "Triamterene, a diuretic drug used in combination with other drugs for the treatment of hypertension, was found in the blood and urine of a fatal aircraft accident victim. "
11/01/1979 - "Triamterene was administered in a dose of 100 mg/day for 8 days to 7 patients with essential hypertension. "
11/01/1979 - "Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension."
12/01/1972 - "The effect of triamterene on plasma and extracellular fluid volume and blood pressure in ten thiazide-treated hypokalemic patients with essential hypertension."
11/01/1969 - "[Administration of triamterene in congestive heart failure]."
08/15/1964 - "Triamterene therapy was evaluated in 35 patients with congestive heart failure over a period of two and one-half years. "
08/15/1964 - "CLINICAL EXPERIENCE WITH A NEW DIURETIC, TRIAMTERENE, IN CONJESTIVE HEART FAILURE."
01/01/1985 - "Piretanide (6 mg once daily) and piretanide plus triamterene (6 mg + 50 mg once daily) both produced a significant reduction in certain symptoms of congestive heart failure which was evident at 2 weeks and was maintained and further enhanced over the ensuing 12-week trial period. "
01/01/1985 - "Improvement in a number of symptoms of congestive heart failure was attained in 54% of the patients in the piretanide group and 67% in the piretanide plus triamterene group. "
06/01/1984 - "There was 92% reduction in apparent oral clearance of triamterene (134 +/- 42 ml/min) in patients with cirrhosis. "
05/01/1968 - "[Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis]."
02/01/1988 - "Kinetics and dynamics of triamterene at steady-state in patients with cirrhosis."
06/01/1984 - "These changes in triamterene kinetics in patients with cirrhosis resulted in prolongation of its natriuretic effect, which lasted for up to 48 hr, whereas it was only 8 hr in the controls. "
06/01/1984 - "Triamterene kinetics and dynamics in cirrhosis."
10/01/2014 - "Hypokalemia risk is influenced by age and dosage, and is still increased if used in combination with triamterene."
06/01/1995 - "Once the diagnosis of Liddle's syndrome was suspected, all patients were treated with either triamterene or ameloride, with resolution of hypokalemia and correction of hypertension occurring within 5 to 7 days. "
11/01/1985 - "Potassium chloride was compared with triamterene in a crossover trial involving 16 hypertensive patients with overt diuretic-induced hypokalemia. "
03/01/1989 - "A combination of hydrochlorothiazide and triamterene had been previously prescribed despite no history of hypokalemia. "
09/01/1987 - "Results indicate that K salt supplementation did not reverse the gossypol-related hypokalemia and that the blocking agent triamterene did not prevent loss of or enhance the retention of serum K. "
01/01/1982 - "An estimated 150 to 200 calculi with triamterene are probably eliminated though not detected every year in France. "
03/01/1987 - "Triamterene calculus]."
02/01/1986 - "The saturation of urine with triamterene and especially with the sulfate ester, 3, may be related to stone formation, but other physical factors play a role in determining the relative amounts of drug found in calculus material."
06/01/1985 - "Triamterene calculus."
01/01/1982 - "The composition of drug layers is almost the same in the 4 calculi and shows a mixture of triamterene (estimated at 35% of iatrogenic components) and 7 metabolites among them p-hydroxy-triamterene (5-10%) and mainly p-hydroxytriamterene estersulfate (40-55%). "
|8.||Dihydrotachysterol (AT 10)
|9.||Leucovorin (Folinic Acid)
|1.||Sodium-Restricted Diet (Diet, Sodium Restricted)
|4.||Protein-Restricted Diet (Diet, Protein Restricted)